BioSight
Companies
Cardiol Therapeutics Inc. logo

CRDL

NASDAQOAKVILLE, A6
Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on inflammation and fibrosis in cardiovascular diseases, including acute myocarditis, recurrent pericarditis, and heart failure. The company is developing product candidates using proprietary delivery technologies to target inflamed and fibrotic tissue, with plans to develop multiple routes of administration and formulations for clinical studies and commercialization.

Price history not yet available for CRDL.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar